These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 28923174)

  • 21. The estrogen receptor as a mediator of the pathological actions of cholesterol in breast cancer.
    McDonnell DP; Chang CY; Nelson ER
    Climacteric; 2014 Dec; 17 Suppl 2(0 2):60-5. PubMed ID: 25320023
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of angiogenesis by selective estrogen receptor modulators through blockade of cholesterol trafficking rather than estrogen receptor antagonism.
    Shim JS; Li RJ; Lv J; Head SA; Yang EJ; Liu JO
    Cancer Lett; 2015 Jun; 362(1):106-15. PubMed ID: 25799952
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estrogen receptors as targets for drug development for breast cancer, osteoporosis and cardiovascular diseases.
    Thomas T; Gallo MA; Thomas TJ
    Curr Cancer Drug Targets; 2004 Sep; 4(6):483-99. PubMed ID: 15379634
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular mechanisms of selective estrogen receptor modulator (SERM) action.
    Dutertre M; Smith CL
    J Pharmacol Exp Ther; 2000 Nov; 295(2):431-7. PubMed ID: 11046073
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Breast cancer and (25R)-26-hydroxycholesterol.
    Javitt NB
    Steroids; 2015 Dec; 104():61-4. PubMed ID: 26299212
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Selective estrogen receptor modulators (SERMs) in the practice].
    Nagykálnai T
    Magy Onkol; 2002; 46(2):165-75. PubMed ID: 12202896
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The ROS-mediated activation of IL-6/STAT3 signaling pathway is involved in the 27-hydroxycholesterol-induced cellular senescence in nerve cells.
    Liu J; Liu Y; Chen J; Hu C; Teng M; Jiao K; Shen Z; Zhu D; Yue J; Li Z; Li Y
    Toxicol In Vitro; 2017 Dec; 45(Pt 1):10-18. PubMed ID: 28739487
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Our evolving understanding of how 27-hydroxycholesterol influences cancer.
    Ma L; Cho W; Nelson ER
    Biochem Pharmacol; 2022 Feb; 196():114621. PubMed ID: 34043965
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective estrogen-receptor modulators and antihormonal resistance in breast cancer.
    Jordan VC; O'Malley BW
    J Clin Oncol; 2007 Dec; 25(36):5815-24. PubMed ID: 17893378
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of SERMs for treatment in postmenopausal women.
    Pinkerton JV; Thomas S
    J Steroid Biochem Mol Biol; 2014 Jul; 142():142-54. PubMed ID: 24373794
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evolution of the tissue selective estrogen complex (TSEC).
    Komm BS; Mirkin S
    J Cell Physiol; 2013 Jul; 228(7):1423-7. PubMed ID: 23359290
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Cholesterol Metabolite 27HC Increases Secretion of Extracellular Vesicles Which Promote Breast Cancer Progression.
    Baek AE; Krawczynska N; Das Gupta A; Dvoretskiy SV; You S; Park J; Deng YH; Sorrells JE; Smith BP; Ma L; Nelson AT; McDowell HB; Sprenger A; Henn MA; Madak-Erdogan Z; Kong H; Boppart SA; Boppart MD; Nelson ER
    Endocrinology; 2021 Jul; 162(7):. PubMed ID: 33959755
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A High-Cholesterol Diet Increases 27-Hydroxycholesterol and Modifies Estrogen Receptor Expression and Neurodegeneration in Rabbit Hippocampus.
    Brooks SW; Dykes AC; Schreurs BG
    J Alzheimers Dis; 2017; 56(1):185-196. PubMed ID: 27911307
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estrogen receptors: selective ligands, partners, and distinctive pharmacology.
    Katzenellenbogen BS; Montano MM; Ediger TR; Sun J; Ekena K; Lazennec G; Martini PG; McInerney EM; Delage-Mourroux R; Weis K; Katzenellenbogen JA
    Recent Prog Horm Res; 2000; 55():163-93; discussion 194-5. PubMed ID: 11036937
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of 27-hydroxylase (CYP27A1) and 27-hydroxycholesterol in breast cancer.
    Kimbung S; Chang CY; Bendahl PO; Dubois L; Thompson JW; McDonnell DP; Borgquist S
    Endocr Relat Cancer; 2017 Jul; 24(7):339-349. PubMed ID: 28442559
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sex-opposed inflammatory effects of 27-hydroxycholesterol are mediated via differences in estrogen signaling.
    Houben T; Bitorina AV; Oligschlaeger Y; Jeurissen ML; Rensen S; Köhler SE; Westerterp M; Lütjohann D; Theys J; Romano A; Plat J; Shiri-Sverdlov R
    J Pathol; 2020 Aug; 251(4):429-439. PubMed ID: 32472585
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selective estrogen receptor modulators: an update on recent clinical findings.
    Shelly W; Draper MW; Krishnan V; Wong M; Jaffe RB
    Obstet Gynecol Surv; 2008 Mar; 63(3):163-81. PubMed ID: 18279543
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between lifestyle, dietary, reproductive, and anthropometric factors and circulating 27-hydroxycholesterol in EPIC-Heidelberg.
    Le Cornet C; Johnson TS; Lu DL; Kaaks R; Fortner RT
    Cancer Causes Control; 2020 Feb; 31(2):181-192. PubMed ID: 31938951
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular perspectives on selective estrogen receptor modulators (SERMs): progress in understanding their tissue-specific agonist and antagonist actions.
    Lonard DM; Smith CL
    Steroids; 2002 Jan; 67(1):15-24. PubMed ID: 11728517
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selective estrogen receptor modulators in clinical practice: a safety overview.
    Ellis AJ; Hendrick VM; Williams R; Komm BS
    Expert Opin Drug Saf; 2015 Jun; 14(6):921-34. PubMed ID: 25936229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.